通过ACOX3的多组组特征分析,揭示了潜在的泛癌临床生物标志物
Wan-Li Wang1, Qiao Xiong2, Bo Ma1
1State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases & Department of Oral and Maxillofacial Surgery, West China Hospital of Stomatology, Sichuan University, China.
Computational biology and chemistry
|December 18, 2025
概括
乙-甲酸氧化酶3 (ACOX3) 显示为一种泛癌生物标志物具有前途. 它的表达影响患者的预后,并与瘤免疫相互作用,表明治疗潜力.
科学领域:
- 在瘤学瘤学.
- 生物标志物发现发现
- 癌症基因组学 癌症基因组学
背景情况:
- 乙基-CoA氧化酶3 (ACOX3) 涉及到各种细胞过程.
- 它作为胰腺癌生物标志物的作用在很大程度上仍然未被描述.
研究的目的:
- 为了全面描述ACOX3作为一种新的胰腺癌生物标志物.
- 评估其表达异质性,临床相关性,瘤免疫相互作用和多种癌症类型的治疗潜力.
主要方法:
- 对ACOX3表达的多个omics分析.
- 使用考克斯回归,卡普兰-梅尔生存率和ROC分析进行预后和诊断意义评估.
- 免疫细胞透,检查点和免疫调节活性评估.
- 通过分子对接和动态模拟来预测药物敏感性.
- 在头部和部状细胞癌 (HNSCC) 细胞系中的实验验验证.
主要成果:
- 在不同癌症类型中,ACOX3的表达有显著的差异,在KICH,PRAD,THCA上调,在COAD,HNSCC,KIRP,LIHC,STAD下调.
- 高ACOX3表达与HNSCC的良好预后相关,但在LGG和UVM中结果不佳.
- 在HNSCC中,ACOX3表达与CD4+ T,CD8+ T和NK细胞正相关,恶性区域的丰富.
- 确定AZD6482和TGX-221是高亲和度的ACOX3抑制剂,AZD6482显示稳定结合.
- 过度表达ACOX3抑制了HNSCC细胞的增殖,入侵和迁移.
结论:
- ACOX3作为一个双重的诊断和预后生物标志物,具有广泛的泛癌相关性.
- 鉴定了ACOX3.3的明显的免疫相关物和治疗潜力.
- 需要对针对ACOX3的治疗方法进行进一步的研究.
相关概念视频
Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
Cancer-Critical Genes II: Tumor Suppressor Genes
9.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K
Cancer Survival Analysis
629
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
629
Cancer-Critical Genes I: Proto-oncogenes
11.1K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.1K
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K


